首页> 外国专利> Immediate Release Pharmaceutical compositions comprising oxycodone and naloxone. Use

Immediate Release Pharmaceutical compositions comprising oxycodone and naloxone. Use

机译:立即释放包含羟考酮和纳洛酮的药物组合物。采用

摘要

Item 1: immediate release of oral drug ingredients, characterized by at least oxygen elbow or acceptable salt and naloxone on the drug or acceptable salt on one drug, at a weight of about 2:1 (oxygen elbow or acceptable salt): If you are already registered, please log in first. Requirement 4: an oral drug ingredient is released immediately, according to any requirement, 1, 2 or 3, which is characterized by a formula containing a quantity of oxycodone, or a pharmaceutically acceptable salt,Equivalent to about 1 mg of oxyelbow hydrochloride up to 160 mg and a naloxone or a pharmaceutically acceptable salt, equivalent to about 0.5 mg of naloxone hydrochloride up to 80 mg. Requirement 14: oral drug composition, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13, which is required to be released immediately according to any one of the requirements. It is characterized by: the composition is a plate, a capsule, pluralism, fur or liquid. Request 31: methods of treatment of patients with pain,It is characterized by oral medication according to any requirement, i.e. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or 26.
机译:第1项:立即释放口服药物成分,其特征在于至少有氧气肘或可接受的盐和纳洛酮或药物上的纳洛酮或一种药物具有可接受的盐,重量约为2:1(氧气肘或可接受的盐):如果您是已经注册,请先登录。要求4:根据1、2或3的任何要求,立即释放口服药物成分,其特征在于配方中含有一定量的羟考酮或药学上可接受的盐,相当于约1毫克的盐酸羟肘,直至160毫克的纳洛酮或可药用盐,相当于约0.5毫克的纳洛酮盐酸盐,最高可达80毫克。要求14:口服药物组合物1、2、3、4、5、6、7、8、9、10、11、12或13,需要根据任一要求立即释放。其特征在于:该组合物是板,胶囊,多元性,毛皮或液体。要求31:疼痛患者的治疗方法,其特征是根据任何要求口服药物,即1,2,3,4,5,6,7,8,9,10,11,12,13,14 ,15、16、17、18、19、20、21、22、23、24、25或26。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号